AIOT · Investment summary · as of 3 August 2026
Priced slightly ahead of what the business has demonstrated
Business type: Mature, marginal · scaling but economically observable
At $4.09, AIOT requires a 13% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 8%.
The actual bull thesis (prior memo section 3.2) is FY2027 as the first clean year - GAAP margin converging toward the 22% adjusted-EBITDA margin as merger optics wash out. At consensus growth the price's remaining requirement is entirely on the terminal margin.
Estimates have moved fY2027 EPS revised down $0.14 -> $0.10 across 90 days; FY2028 EPS revised up $0.25 -> $0.335 in the trailing 7 days.
The strongest argument against this view: reflexive goodwill-impairment and refinancing spiral in which the share price is itself the trigger. $412.0m goodwill + $255.5m intangibles = 69.9% of total assets in ONE reporting unit, against $475.5m book equity and -$192.0m tangible book.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The actual bull thesis (prior memo section 3.2) is FY2027 as the first clean year - GAAP margin converging toward the 22% adjusted-EBITDA margin as merger optics wash out. |
| What do we forecast? | Revenue growth of 8% demonstrated; a terminal operating margin of 9%; an exit multiple of 19.1x. |
| What does Street forecast? | FY2027 EPS revised down $0.14 -> $0.10 across 90 days; FY2028 EPS revised up $0.25 -> $0.335 in the trailing 7 days. |
| Where do we differ? | On terminal margin, the difference between what the price requires and what the business has demonstrated is -2.2 percentage points. |
| What is it worth? | Twelve-month target $5.25, +28% from the struck price. Scenario-weighted expected return net of costs +10.4%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| Q1 FY2027 (~Aug 2026), Q2 FY2027 (~Nov 2026) | Same-perimeter revenue growth below +6% YoY in Q1 or Q2 FY2027 | Neither leg of the condition opposite is met at this date | Same-perimeter revenue growth below +6% YoY in Q1 or Q2 FY2027 |
| H1 FY2027 (~Nov 2026) | H1 FY2027 free cash flow below +$5m | Neither leg of the condition opposite is met at this date | H1 FY2027 free cash flow below +$5m |
| Q3 FY2027 (~Feb 2027) | South African Treasury ramp not visible in reported revenue by the Q3… | Neither leg of the condition opposite is met at this date | South African Treasury ramp not visible in reported revenue by the Q3 FY2027 print |
| any FY2027 print | FY2027 revenue guidance cut below $485m, or adjusted-EBITDA guidance… | FY2027 revenue guidance cut at or above $485m, or adjusted-EBITDA guidance cut below $120m, at any print | FY2027 revenue guidance cut below $485m, or adjusted-EBITDA guidance cut below $120m, at any print |
Reflexive goodwill-impairment and refinancing spiral in which the share price is itself the trigger. $412.0m goodwill + $255.5m intangibles = 69.9% of total assets in ONE reporting unit, against $475.5m book equity and -$192.0m tangible book. Scenario: H1 FY2027 FCF misses the guided $40-45m swing (most likely proximate cause: a slower SA Treasury ramp - sovereign counterparty, ZAR), guidance cut, stock revisits $2.79, the 1 October 2026 annual test runs against a market cap a control premium cannot bridge, non-cash write-down lands into the ~Feb 2027 RMB refinancing window on 2.47x net leverage with $50.4m short-term borrowings. not going-concern, argued: FY2026 OCF +$30.5m, liquidity $63.6m, a write-down is non-cash and breaches no leverage covenant per se.
Estimated probability 20%, against the 24% level at which the position would be resized. It sits within that level.
Falsifiable and fundamental — not one of them is a price condition.
On approach to the $5.25 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Growing (~8% organic) but neither compounding nor inflecting: 'not a failure state, simply not a growth-mandate name.' Compounding economics absent (ROIC ~1.9% FY26A / ~4.1% FY27E vs WACC 12.8%; $568m deployed -> $305m goodwill, legacy revenue -1.0%); inflection economics absent (+2.7pp adjusted op-margin delta vs ~5pp separation; value not terminal). |
| Valuation | Not met | Required 12.77% organic revenue CAGR for 5 years at terminal margin 9.3%, exit 19.1x EV/EBIT, WACC 12.78% - vs 8.0% demonstrated ORGANIC. |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | Reflexive goodwill-impairment and refinancing spiral in which the share price is itself the trigger. $412.0m goodwill + $255.5m intangibles = 69.9% of total assets in ONE reporting unit, against $475.5m book equity and -$192.0m tangible book. |
| Momentum | Met | Sign flipped positive in five weeks. 12m total +7.6%; 45% of 52-week range ($2.79-$5.66); above the 50-day ($3.99), below the 200-day ($4.22). |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -2.2 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: reflexive goodwill-impairment and refinancing spiral in which the share price is itself the trigger. $412.0m goodwill + $255.5m intangibles = 69.9% of total assets in ONE reporting unit, against $475.5m book equity and -$192.0m tangible book. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $3.56, which forces an immediate review.